The U.S. cath labs market size is expected to reach USD 24.3 billion by 2027, expanding at a CAGR of 5.3%, according to a new report by Grand View Research, Inc. The growing prevalence of cardiovascular diseases, the increasing number of coronary angiography performed each year, and the aging population prone to various heart problems, are the major factors driving the market. In addition, technological advancements and a growing preference for robot-assisted minimally invasive surgeries are other key factors propelling the growth of the market.
According to the American Heart Association (AHA), coronary artery disease affects 16.5 million Americans. The elective Percutaneous Coronary Intervention (PCI) is a commonly performed procedure in the U.S, with around 600,000 procedures performed each year. These procedures have the highest aggregate costs of all cardiovascular procedures, and PCI also has the third-highest aggregate cost of any surgical procedure, estimated at about USD 10.0 billion annually.
Browse Full Report (Tables & Figures) @ https://www.grandviewresearch.com/industry-analysis/us-cath-labs-market
Contact Us:
Grand View Research, Inc.
201 Spear Street 1100,
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]